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ABSTRACT
A reaction involving iron as an intermediary electron carrier for the
coupling of electron transfer from an endogenous substrate to ferroxidase-I
has been proposed.
The enzymic nature of the reaction has been established and studies
with iron chelating agents have demonstrated the involvement of Fe(III).
The kinetic parameters of ferroxidase-11 with Fe(lll) were found to be
quite similar to those previously established for Fe(Il). The participation by the copper associated with ferroxidase-11 was ascertained by use
of the copper chelating agent, diethyl-dithio-carbamate.
A variety of substances normally found in blood were surveyed as possible candidates for the endogenous substrate but none were oxidized by
ferroxidase-11 in a coupled reaction with Fe(lll).

Comp)ete loss of the

Fe(lll)-initiated oxidase activity was observed when ferroxidase-11 was
treated with phospholipase C and passed over a column of Agarose A-5m.
This procedure removes the bound lipid from ferroxidase-lI and the loss
of activity observed suggested that the endogenous substrate was a lipid
or was dissolved in the lipid matrix of the enzyme.
tute this

activi~

Attempts to reconsti-

with lipid extracts of ferroxidase-11 were unsuccessful.

The endogenous substrate responsible for the Fe(Ill)-initiated reaction
was not definitely identified; however, significant progress towards its
characterization was made.

LITERATURE

REVIEl~

The element copper is fundamental to the life processes of both
plants and animals.

Copper has long been a familiar element but its

presence in biological systems has been known for only 150 years.

One

of the reasons its presence has gone undetected until recent times is
that copper deficiency is rare in plants and has never been observed in
animals. This is due to the natural abundance of copper in the diet.
An excess of copper could be toxic but the protective mechanisms in the
body restrict the absorption of copper and other metals.
Copper's importance arises from the fact that it is a required constituent of numerous essential proteins and enzymes.

Although the amount

of copper required by organisms is quite small, it is indispensable to
the life processes.

The adult human body contains only about 100

m~lli

grams of copper, a small amount, but one which is vital to our existence.
In living systems it is very difficult to determine precise forms
and locations of copper.

This is true because copper is seldom found in

any biological compound less complicated than a protein.

Nearly all of

the 100 milligrams of copper in the human body is incorporated into proteins.

A few of the copper proteins are given in Table I.

There are primarily three properties which make copper so ideally
suited for metabolic processes(l):
1.
2.
3.

copper ions react with amino acids or proteins more
strongly than other metal ions do
copper is an exceptionally effective catalytic agent
copper's ionization states have flexible properties
that qualify it uniquely for metabolic functions

The element copper is a member of the first transition series.

Sev-

eral of the elements of this series share these three important properties
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TABLE I
IMPORTANT COPPER PROTEINS AND ENZYMES

Name

Where Found

Cytochrome
oxidase

Most plants and
animals

Hemocyanin

Mollusk and arthropod plasma

mo!.wt
10 gm
70
450-

Biochemical
Function
Termi na 1 oxi dase
Oxygen carrier

6, 680

Ceruloplasmin

Plasma of most
animals

l 51

Fe(III)-transferrin
formation, Copper
transport

Amine oxidase

Most animals, etc.

225

Elastin, collagen
formation

Tyrosinase

Animal skin,
melanoma, insects,
pl ante::.

35
100

Tyrosine oxidation,
skin pigment
(melanin) formation

Dopamine-shydroxylase

Adrenals

290

Epinephrine
biosynthesis

Ga lactose
oxidase

Molds

75

Galactose oxidation

Erythrocuprein

Red blood cells of
most animals

34

Superoxide dismutase

Ascorbic acid
oxidase

Many plants

Plastocyanin

Algae, green leaves
and other plants

150

21

Terminal oxidase
Photosynthesis

and also serve as biological trace elements.

Although they do serve as

trace elements, each is very specific in its function.
Research concerning the biological role of copper has greatly expanded since the recognition of its involvement in a number of important
physiological processes(2,3,4).

The best known of these is copper's in-

volvement in hemoglobin formation(5,6,7).
The principal metabolic disturbances arising as a result of copper
deficiency are as follows(8):
1.
2.
3.
4.

reduction in the absorption and utilization of iron
leading to hypochromic and microcytic anemia and a
deficiency of heme enzymes including cytochrome oxidase
a defect in phospholipid biosynthesis resulting in
demyelination and 11 swayback 11 disease in lambs
impairment of osteoblastic activity leading in some animals to skeletal changes similar to those reported in
scurvy
abnormalities in keratin and pigment formation resulting
in wool defects in lambs and achromotrichia in rats

In 1928, Hart et al(5) were the first to report anemia in copperdeficient animals.

Since the early 1950's, Cartwright, Wintrobe, and

their associates at the University of Utah School of Medicine have done
extensive research on this defect in iron metabolism.

Their studies led

them to propose a role for copper in the biosynthesis of hemoglobin(7,9).
They theorized that copper could act at any of the three main lines of
hemoglobin biosynthesis:

the biosynthesis of protoporphyrin of heme, the

utilization of iron, or the biosynthesis of globin.

Earlier work by Lee

et al(lO) showed that as anemia developed there was an increase in the
activity of heme biosynthetic enzymes.

Thus, it did not appear that cop-

per acted at this point of hemoglobin biosynthesis.

Since there was no

evidence for impairment of the biosynthesis of globin, they concluded that
copper was important in the proper utilization of iron(lO).

In 1966) Osaki

et al reported on the possible significance of the ferroxidase activity
of a copper protein, ceruloplasmin.

They proposed that its catalytic

activity involved promoting the rate of iron saturation of transferrin
and iron utilization in the plasma(ll).
Ceruloplasmin was first isolated and characterized in 1947 by the
Swedish biochemists Holmberg and Laurell(l2).

They found the protein to

have a molecular weight of approximately 151 ,000 and a copper content of
eight atoms per molecule.

Ceruloplasmin is found in the plasma of most

vertebrates and normally accounts for over 98% of the serum copper.
Since ceruloplasmin had greater than 98% of the serum copper bound
to it, many believed that ceruloplasmin was directly involved in the transfer of copper.

To test this hypothesis, a radioactive copper salt was

injected into a human body.

The copper first appeared in combination with

the serum albumin in the bloodstream.

From there it was rapidly absorbed

by the liver and finally reappeared in the serum in the fonn of ceruloplasmin(l).

Thus, ceruloplasmin could be a convenient storage form of

copper ion, thereby preventing its interaction with other proteins.
In later studies of ceruloplasmin, Holmberg and Laurell found oxidase
activity in vitro towards many substrates.
activity with p-phenylenediamine(PPD).

They observed max·imum substrate

They also found the activity of

ceruloplasmin to be ma.rkedly affected by anions(l4).

Walaas and coworkers

(15,16) have reported that catecholamines serve as substrates for ceruloplasmin although their reaction rates are slower than those observed with
PPD.

In 1958 Broman reported inhibition of crude ceruloplasmin by dicar-

boxyl ic acids and ethylenediaminetetraacetic acid(l7).

In 1960, Curzon

reported the results of his studies on the effects of some anions, cations
and chelating agents on the oxidase activity of purified ceruloplasmin.
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He observed that low concentrations of metal ions, in particular Fe(II),
increased the activity of ceruloplasmin.

In similar studies Curzon ob-

served inhibition of activity at higher metal ion concentrations(l8).

In

1960, Curzon and O'Reilly(l9) noted the catalytic oxidation of Fe(II) by
ceruloplasmin. Their data indicated a coupled iron-ceruloplasmin oxidation system to be involved.
S. Osaki(20) studied the kinetics of the catalysis of Fe(II) oxidation by crystalline human ferroxidase.

At the pH optimum of 6.5 Osaki

obtained two Km values with respect to Fe(II). Competition between the
two substrates PPD and Fe(II) was also observed(20).
Huber and Frieden(21) found that the ceruloplasmin catalyzed oxidation of Fe(II) and aromatic diamines exhibited nonlinear kinetics in
Eadie-Hofstee plots.

They accounted for the kinetics of Fe(II) oxidation

by a mechanism based on substrate activation.
In a subsequent study, Huber and Frieden studied the inhibition of
ferroxidase by trivalent and other metal ions.

They observed inhibition

with all trivalent ions tested but strongest inhibition was from those
ions which had an ionic radius of 0.81A or less(22).
As reported earlier, Osaki et al(ll) were interested in the role of
ceruloplasmin in hemoglobin biosynthesis.

In 1966, they reinvestigated

the problem of serum Fe( II) oxidation under conditions approaching the
state in vivo.

They estimated the nonenzymic oxidation of Fe(II) to be

insufficient to account for a rate of Fe(III)-transferrin formation necessary to provide adequate iron supply for hemoglobin and other biosyntheses requiring Fe(II).

These results suggested an appreciable catalytic

activity was involved in Fe(II) oxidation in serum.

From their work they

proposed a biological role for ceruloplasmin in converting Fe(II) to Fe(III),

I

thereby promoting the rate of incorporation of Fe(III) into apotransferrin.
This leads directly to the biosynthesis of hemoglobin and other iron-utilizing systems(23).

The possible role of ceruloplasmin is illustrated below(ll):

H2 0 xceruloplasminx2Fe(II)
1/20 2

reduced
ceruloplasmin

2Fe(III)
""\

r

..
apotrans ferri n

transferrin
The ferroxidase activity of ceruloplasmin explains its broad capacity
to catalyze the oxidation of a variety of reducing agents, all of which
react with ferric ion.

Thus it was proposed(ll) that when describing the

enzymic activity of ceruloplasmin, it be designated as a ferro-0 2 -oxidoreductase or simply ferroxidase.

Thus, the term ferroxidase is often used

to describe ceruloplasmin's catalytic activity and its specific role in
iron mobilization.
Johnson, Osaki and Frieden reported a very strong positive linear
correlation between PPD oxidase activity and ferroxidase activity(24).
With the exception of Wilson's disease sera, this correlation was observed
in normal as well as in pathological sera.
There is now considerable evidence supporting the proposal that
ceruloplasmin is the key link between iron and copper metabolism.

The

best evidence comes from Ragan et al(25) at the University of Utah School
of Medicine.

They observed a rapid rise in plasma iron upon injection of

ceruloplasmin in in vivo studies with copper-deficient pigs.
Subsequent studies

by

Cartwright, Lee and coworkers have demonstrated

that a rise in serum ferroxidase activity precedes a rise in serum iron
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following copper injection.

This rise in plasma iron concentration was

followed by a gradual rise in the hemoglobin concentration of the blood
stream(26).

These experiments at the University of Utah indicated that

the defect in the release of iron in the copper-deficient animal is quickly
reversed by intravenous ceruloplasmin(l3).

Osaki et al confirmed these

results in their studies of iron mobilization from perfused mammalian
livers(27,28).
Although the evidence for the role of ceruloplasmin in iron mobilization was quite strong(ll ,13,25,26,27,28), there was no explanation·for
the normal iron mobilization found in Wilson's disease (Hepatolenticular
Degeneration).
In Wilson's disease, the serum is largely depleted of ceruloplasmin
and copper diffuses into the tissues.

The copper may then accumulate to

high levels, especially in the liver and brain.

If ceruloplasmin were the

only ferroxidase in the sera, the Fe(II) oxidase activity would be expected
to be reduced and a defect in iron metabolism should be observed.

Johnson

et al observed reduced PPD oxidase activity but there was still an appreciable
Fe(II) oxidase activity(24).

Thus, despite the reduction in ceruloplasmin,

sufficient ferroxidase activity remained to prevent anemia(29).

This find-

indicated the possibility of the presence of a modified ferroxidase or an
additional unknown catalyst(29).
In 1970, Topham and Frieden announced the identification and purification of a second serum ferroxidase which they designated ferroxidase-II.
They isolated this non-ceruloplasmin ferroxidase protein from normal as
well as Wilson's disease sera(30).
Some of the properties distinguishing ferroxidase-II from ceruloplasmin
are given in Table II(30)-_

Three of the primary differences are that

TABLE II
PROPERTIES DISTINGUISHING FERROXIDASE-II FROM CERULOPLASMIN
PROPERTY

CERULOPLASMIN

Inhibition with lmM
Azide

>

FERROXIDASE-II

98%

None

Apparent Km values for
Fe(II)

2

Specific activity
(A4GO per lOmin per
mg of protein)

30

4.9

p-Phenylenediamine oxidase
activity

Yes

None

1

Elution after
chromatographya

.2 to .3M
NaCl required

No NaCl required

Color of purified
preparation

Blue

Yellow

Molecular Weight

151,000

·Copper content(millimicromoles of copper
per mg of protein)
Immunoelectrophoretic
migration from origin
Effect of dialysisb

rv

>

800,000

44

12

Large

Small

35% remaining
activity

100% activity

aAdsorption on DEAE-Sephadex; eluted with .OSM Acetate buffer,
pH 5.5, with or without .2 to .3M NaCl
boialysis for 2 days at 4°C against .05M Acetate buffer, pH 5.5
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ferroxidase-II:
l.
2.
3.

is yellow rather than blue as ceruloplasmin
is not inhibited by azide
exhibits no PPD oxidase activity

Topham observed that oxygen consumption with ferroxidase-II occurred
simultaneously with iron oxidation.
Topham and Frieden found that although ferroxidase-II was decreased
in Wilson's disease serum it was reduced to a lesser extent than ferroxidase-I.

They observed the total ferroxidase activity of Wilson's disease

serum to be approximately 5 to 10% of that of normal serum(30).

Osaki

et al(28) had previously reported that only about 10% of the total ferroxidase activity of normal serum was necessary for maximum iron mobilization response from the liver.

Thus, the total ferroxidase activity of

Wilson's disease serum accoLlnts for the maintenance of near normal iron
metabolism(30).
Gel filtration data and disc gel electrophoresis indicated that ferroxidase-II had a molecular weight greater than 800,000.

Immunoelectro-

phoretic mobility, the oil red-staining property, and the large molecular
weight suggested that it might be a serum lipoprotein(30).
Sung and Topham(31,32) have recently reported the identification and
quantitative analyses of the lipid components bound to ferroxidase-II.
They found ferroxidase-II to contain lipids both in the form of cholesterol
and phospholipid.

Thin-layer chromatographic analyses were carried out

to determine which individual phospholipids were bound to ferroxidase-II.
Their findings indicated that phosphatidyl choline accounted for most of
the bound phospholipid with small amounts of sphingomyelin and lysophosphatidyl choline accounting for most of the remaining phospholipid(31 ,32,33).
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They also found that intact phospholipids appear essential for the enzymic
activity of ferroxidase-II to be maintained.
Topham et al(34,35) have reported a detailed study of the kinetics
of Fe(II) oxidation by ferroxidase-II.
Table III.

Their findings are presented in

Their results suggest that ferroxidase-II would be capable of

functioning as an alternative for ferroxidase-I in human sera and as the
major ferroxidase in the sera of species having low ferroxidase-I levels.

12

TABLE III
COMPARISON OF THE KINETIC PARAMETERS OF
FERROXIDASE-I AND FERROXIDASE-II
FERROXIDASE-I

FERROXIDASE-II

6.5

7.2

0.6, 50

14

K for 0 2 ( µM)
m
Molar activity (µM Fe
(III)/min)/{µM enzyme)

9.0

4. 1

550

525a

Activity per Cu atom
{µM Fe(III)/min)/(Cu
atom)

69

53

PROPERTY
pH optimum
Km ( s) for Fe(II) {µM)

acalculated assuming a molecular weight of 8 x 10 5 which was
estimated from gel filtration and disc-gel polyacrylamide
electrophoresis(32).
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INTRODUCTION
Huber and Frieden(22) previously reported that certain metal ions
markedly influence the ferroxidase reaction catalyzed by ferroxidase-I.
Substrate activation was observed with iron, whereas inhibition was
observed with certain trivalent and other metal ions.

These studies

provided considerable insight into the molecular mechanism of the ferroxidase reaction catalyzed by ferroxidase-I.
This thesis proposed to undertake similar experiments with ferroxidaseII in the hopes of 1) further differentiating ferroxidase-II from ferroxidase-I and 2) providing information concerning the molecular mechanism
of the ferroxidase reaction catalyzed by ferroxidase-II.
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EXPERIMENTAL METHODS
Isolation and Purification of Ferroxidase-II from.Human Plasma
Pure ferroxidase-II was prepared from the Cohn IV-1 fraction of
human plasma.

The method was an adaptation of the procedure used

previously by Topham and Frieden (30).

This plasma fraction contains

ceruloplasmin (ferroxidase-1) and ferroxidase-II as well as other contaminating proteins but contains only 5% of the total protein of blood
plasma. Thus, Cohn IV-1 is an excellent starting material for the purification of ferroxidase-II.

Five grams of lyophilized Cohn IV-1

{obtained from the E. R. Squibb and Sons, Inc., New York, New York) was
extracted with 100 ml of 0.05 Macetate buffer, pH 5.5, overnight at 4°
with gentie continuous stirring.

In order to remove any undissolved

material, the resulting extract was centrifuged at 25,000 x gravity for
30 minutes at 4°. The supernatant was then decanted through a thin
layer of fine glass wool to remove the floating lipid layer.
At pH 5.5 ferroxidase-I and ferroxidase-II differ greatly in charge.
At this pH, ceruloplasmin is highly negatively charged; however, ferroxidase-II bears little charge. Thus, these two proteins may be completely
separated by chromatography on an anion exchange resin, DEAE-Sephadex

A~50.

The entire extract of Cohn IV-1 was chromatographed on a DEAE-Sephadex A-50
column (4 cm x 10 cm).
pH 5.5.

The column was washed with 0.05 M acetate buffer,

Ferroxidase-II was eluted immediately following the void volume

with 0.05 Macetate buffer, pH 5.5.
a turbid yellow solution.

Ferroxidase-II came off the column as

Ferroxidase-I remained as a small blue-green

band at the top of the column.

The ferroxidase-II containing solution

was then concentrated to 30 ml by ultrafiltration in an Amicon ultrafiltration
cell equipped with a Diafl6 PM-30 membrane.
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For further purification, the concentrated ferroxidase-II solution
was applied to an Agarose A-50 M column (4 cm x 55 cm).

Agarose A-50 M

is a molecular sieving gel for proteins of molecular weight 10 x 10 4
50 x 106.

t·

Two bands having ferroxidase activity were eluted with 0.05 M

acetate buffer, pH 5.5.

The first band was yellowish and very turbid and

contained 10 - 12% of the ferroxidase-II activity.

Approximately 90% of

the ferroxidase-II activity was eluted as a second band which was clear
yellow in color.

This band was collected, concentrated to approximately

30 ml and passed through another Agarose A-50 M column (4 cm x 55 cm).
A clear yellow protein band possessing ferroxidase-II activity was eluted
from this column.

This band was then concentrated to a final protein

concentration of approximately 20 mg/ml.
Quantitative Determination of Protein
Protein concentrations were determined by the method of O.H. Lowry (36).
This is a spectrophotometric assay combining the use of the biuret and
phenol reagents.

There are basically two steps which lead to the final

color with the protein.

In the biuret reaction, the protein reacts with

a strongly alkaline, but dilute solution of copper sulfate producing a
violet color.

The second step involves the reduction of the phosphomolyb-

dic-phosphotungstic reagent (Phenol Reagent) by the copper-treated protein.
The reduction of this reagent is due to the tyrosine and tryptophane present
in the protein.

This method has the advantages of being rapid, sensitive

and specific for protein.

The limit of detection is 5 pg/ml with a sen-

sitivity 100 times that of the biuret reaction and 10-20 times the value
obtained by measurement of the ultraviolet absorption at 280 nm.
In the analysis, duplicate one ml samples of a bovine serum albumin
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solution (0.2 mg/ml} and 1 ml of a distilled water blank were placed
into colorimetric tubes.

The solution of unknown protein concentration

was diluted 1:10 (v/v} and l ml was placed into a colorimetric tube.
Five ml of Lowry B solution (2% Na 2 C0 3 ; 0.1 M NaOH; 0.01% CuS0 4 ; 0.02%
sodium tartrate} were then added to the tubes which were mixed and allowed to stand ten minutes.

After ten minutes, 0.5 ml of phenol reagent

(Phipps and Bird, Richmond, Virgin~a; diluted 1/1 with water) was added
to each tube.

Maximum color was developed in one hour, at which time,

the absorbance of each tube at 600 nm was recorded.
Method of Assay of Enzymic Activity
Ferroxidase assays were carried out using the Gilson Model K-ICC-RP
Oxygraph with a Clark-type polarographic oxygen electrode.

The basis of

the procedure is illustrated in the following equations:
(1)

Fe2+ + E

ox

+

Fe 3+ + E
red

(2)

The cell containing the electrode system was maintained at 30°C
with a Haake FJ thermostatted bath.

The instrument was standardized at

30°C assuming the oxygen concentration of air saturated water to be 236
micromolar (35}.
The standard polarographic assay procedure for ferroxidase activity
was conducted in the manner outlined below.

The reaction mixture used

for assays contained 7 parts by volume of 0.6 M acetate buffer, pH 6.0
(final concentration 0.2 M), 6 parts by volume of a 4 x 10-4 M ferrous
ammonium sulfate solution (final concentration 120 micromolar}, and 5
parts by volume of distilled water.

For each assay, 2 ml of the reaction

mixture was pipetted into the reaction vessel and allowed to equilibrate.
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Once a steady base line was established, 50 µl of the enzyme preparation
was injected and the rate of oxygen consumption was recorded.

The specific

activity was recorded as micromoles of oxygen consumed per minute per mg
protein.
In order to study the enzymic activity with the ferric ion, it was
necessary to make a slight modification of the above procedure.

For these

analyses, a reaction mixture containing 0.6 M acetate buffer, pH 6.0
diluted 1:3 (v/v) was used.

A series of standard iron (III) solutions

were made and varying amounts of these were injected into the reaction
vessel.

As before, the specific activity was recorded as micromoles of

oxygen consumed per minute per mg protein.
Any variations from the standard procedure will be specifically
enumerated in the legends to the figures or tables resulting from these
special experiments.
Treatment of Ferroxidase-II with Phospholipase C
Phospholipase C treatments were performed according to the method of
Topham and Gaylor (37) and Sung and Topham (32).

Four ml of purified

ferroxidase-II (18 mg/ml), 0.7 mg of phospholipase C (Type 1) and 0.145 ml
of 0.4 MCaC1 2 were incubated for two hours at 30°. Controls containing
purified ferroxidase-II·, CaC1 2 , but no phospholipase C were incubated under
identical conditions.

After incubation, the ferroxidase activities of the

samples and of the controls were determined.
Spectral Studies of Fe(III) Reduction by Ferroxidase-II
Spectral studies of the enzyme catalyzed reaction were performed
using a Perkin-Elmer Model 450 UV-Visible NIR spectrophotometer.
instrument was used in the double beam mode.

The
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These experiments were designed to determine whether Fe(III) was
being reduced in a coupled reaction with ferroxidase-II.

The basic com-

ponents of the reference and sample cells were as follows:
Reference cell: reaction mixture (0.2 MAcetate buffer, pH 6.0)
containing 1 x 10- 2 Ma,a'-dipyridyl or 1 x 10- 2 M1 ,10-phenanthroline, 1 x 10- 3 MFe(III), 100 µl of 0.05 MAcetate buffer,
pH 5.5
Sample cell: reaction mixture (0.2 MAcetate buffer, pH 6.0) containing 1 x io- 2 Ma,a'-dipyridyl or 1 x io- 2 M 1,10-Phenanthroline, 1 x 10- 3 M Fe(III), 100 µl{0.91 mg) ferroxidase-II
Control spectra were run to determine the absorbance of the various components of the reference and sample cell.
To determine the absorbance of ferroxidase-II, the reference cell
contained the reaction mixture and 100 µl of 0.05 MAcetate buffer, pH 5.5.
In the sample cell, 100 µl{0.91 mg) of ferroxidase-II was substituted for
the Acetate buffer.
The possible absorbance by Fe(III) and ferroxidase-II was examined
by addition of l x 10- 3 M Fe(III) to the sample and reference cell used
to determine the absorbance of ferroxidase-II.
To look at the absorbance due to the chelating agents and the enzyme,
the sample and reference cells included the following:
Reference cell: reaction mixture (0.2 MAcetate buffer, pH 6.0)
containing l x 10- 2 Ma,a'-Dipyridyl or 1 x 10-2 M 1,10-Phenanthroline, 100 µl of 0.05 MAcetate buffer, pH 5.5
Sample cell: reaction mixture (0.2 MAcetate buffer pH 6.0) containing 1 x 10- 2 Ma,a'-Dipyridyl or 1 x 10-2 M l ,10-Phenanthroline, 100 µl{0.91 mg) ferroxidase-II
Treatment of Ferroxidase-II with Diethyl-Dithio-Carbamate (OTC)
In order to bind the copper associated with ferroxidase-II, the
enzyme was treated with the copper chelating agent, OTC.

A stock
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solution of 10- 2 M OTC was made in 0.05 M acetate buffer pH 5.5.

This

solution was added to the purified ferroxidase to yield a final OTC .concentration of 10- 3 M.

After standing, the mixture was dialyzed against

acetate buffer to remove excess chelating agent.
Metal Inhibition Studies
To remove trace amounts of contaminating metals, all glassware and
containers were washed with concentrated HCl, then rinsed several times
with glass-distilled water.
Routinely, the reaction mixture (0.6 Macetate buffer diluted 1+3)
was placed in the reaction cell and allowed to equilibrate.

After equil-

ibration, 50 µl(l .04 mg). of ferroxidase-II and varying amounts of standard
Fe(I II) so 1uti ons were added and a11 owed to incubate for two minutes.

Next,

Fe(II) was added (120 µM final concentration) and the reaction was allowed
to proceed. Throughout this procedure, the activity was monitored as micromoles of oxygen consumed per minute.
Extraction of Lipids from Ferroxidase-II
The lipid components of ferroxidase-II were isolated and purified by
the procedure of Folch et al (38).

Routinely, lipids were extracted from

10 ml of ferroxidase-II by stirring overnight with 200 ml of chloroform/
methanol (2:1, v/v).
water.

The extract was then washed with 50 ml of distilled

This resulted in a two phase system with the chloroform (lower).

phase containing the extracted lipids.
the chloroform layer appeared clear.

The washing step was repeated until
If an emulsion formed during the

washing procedure, solid NaCl was added as a dispersing agent.

The

chloroform layer was evaporated to 15 ml and an equal volume of 95%
ethanol was added.

This mixture \'-las evaporated to dryness in a tared
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flask under a stream of nitrogen.

The flask was then reweighed and the

yield was determined.
A stock solution of lipids was prepared by dissolving the extracted
lipids in 10 ml of chloroform/methanol (2:1, v/v).

For each experiment,

a quantity of the stock so 1ution was removed, evaporated to dryness and dissolved in the desired solvent. Controls with the solvent in the absence
of the

~xtracted

lipids were also run.
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RESULTS
Frequently, end product inhibition is a mechanism by which cells
control the rate of certain metabolic reactions.

Therefore, the logical

starting point in the investigation of the effect of metal ions on ferroxidase-II seemed to be a study of the effect of Fe(III).

Thus, Fe(III)

was initially examined as a possible inhibitor of ferroxidase-II.
Interaction of Ferroxidase-II with Fe(III)
Unexpectedly, oxygen consumption was observed immediately following
the injection of Fe(III) (Figure 1). This observation suggested that
Fe( III) initiated an oxidase type reaction with ferroxidase'.""II.

Since

Fe(III) is the highest stable oxidation state of iron, the further oxidation of Fe(III) by ferroxidase-II would be extremely unlikely.

Thus,

it appeared that Fe(III) must be initiating the oxidation of some substance endogenous in the ferroxidase-II preparation.

Additional studies

were undertaken to ascertain why Fe(I II) i ni ti ated oxygen consumption with
ferroxi dase-I I.
Enzymic Nature of the Fe(III) Reaction
If the Fe(III)-initiated reaction with ferroxidase-II is indeed an
enzymic process, then saturation kinetics should be observed for the
reaction and heat treatment should result in the loss of the Fe(III)-initiated activity.
A plot (Figure 2) of the specific activity of the Fe(III}-initiated
reaction versus the substrate concentration did exhibit saturation kinetics.
Treatment of ferroxidase-II at 100° for 5 minutes resulted in the complete
loss of the Fe(III)-initiated reaction.
The determination of the basic kinetic parameters of the Fe(III)initiated reaction seemed to be the next logical step.
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FIGURE 1
Time Course of Oxygen Consumption with the Fe(III)-initiated

R~~ction

with Ferroxidase-II
The reaction mixture contained 50

~l

(1.04 mg) of purified ferroxidase-

II and a final Fe(III) concentration of 1 x l0-3 M.
The same activity was observed regardless of the order of addition of
iron and ferroxidase-II.
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FIGURE 2
Velocity of the Ferroxidase Reaction as a Function of Substrate
Concentration
Ferroxidase activities were carried out as described in "Experimental
Methods". The reaction mixture contained 50 µl (0.25 mg) of purified
ferroxidase-II and varying concentrations of Fe(III).

Two entirely separate

experiments were done and in each experiment multiple determinations were
done at each substrate concentration.
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Effect of pH on the Fe(III) Reaction with Ferroxidase-II
The pH optimum for the Fe(III)-ferroxidase-II reaction was determined
by measuring the initial rate of oxygen consumption as a function of pH.
Reaction mixtures were adjusted to specific pH values prior to the
addition of ferroxidase-II or Fe( III).

Since the Fe(III) solutions were

prepared in 0.1 N HCl, it was necessary to remeasure the pH following the
injection of Fe(III).

Maximum oxygen consumption was observed at a pH of

. 7. 0 (Figure 3) .
Determination of Steady-State Kinetic Parameters for the Fe(III)-Initiated
Reaction
To determine the

~for

Fe(III) for ferroxidase-II, the initial

rate of oxygen consumption was measured at various Fe( III) concentrations.
An Eadie-Hofstee plot (v/s vs v) yielded a linear relationship (Figure 4).
The kinetic parameters calculated from this plot were Km Fe( III)
and Vmax = 127 µM 02 /min/mg

= 10 µM

p~otein.

In order to determine the best fitting straight line, a linear regression analysis was performed using the Wang Model 600 programmable
calculator in conjunction with the x,y plotter.
The steady-state kinetic parameters obtained for Fe( III) are compared to those previously determined for Fe(II) in Table 1.
Metal Survey
Studies were performed to determine whether other metals were capable
of initiating oxygen consumption in the same manner as Fe(III).
As seen in Table 2, no other metal ion tested initiated oxygen consumption with ferroxidase-II.
After each of these ions was added, Fe(III) was introduced into the
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FIGURE 3

Effect of pH on the Fe(III) reaction with Ferroxidase-II
Enzymic assays were performed as described in "Experimental Methods 11 •
The assay mixture contained 1 x 10- 3 M Fe( III), 50 µl (0.909 mg) of purified ferroxidase-II and 0.2 Macetate buffer pH 3.85 to 7.42 in a final
volume of 2 ml. The range of the specific activities of several trials
at each pH is shown but the lines are drawn through the average specific
activity at each pH.
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FIGURE 4

Eadie-Hofstee Plot of the Steady-State Kinetic Data for Fe( III)
Enzymic assays were performed as described in

11

Experimental Methods 11 •

Each assay mixture contained 50 µl (0.25 mg) of the purified ferroxidase-II
solution, 0.2 M acetate buffer, pH 6.0, and concentrations of Fe(III) from
0.01 mM to 0.3 mM.

The best fitting straight line was determined by a

linear regression analysis performed on the Wang Model 600 programmable
calculator in conjunction with the x,y plotter.
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TABLE l
Comparison of the Kinetic Parameters of Ferroxidase-II
with Fe(II) and fe(III)
Property
~1 (µM)

Fe( III)
14

lO

Vmax (µM 02 /min/mg protein)

102

127

pH Optimum

7.2

7.0

1These values reported by Topham and Johnson (35)
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TABLE 2
Effect of Metal Ions on Ferroxidase-II Activity
Cation
(1 x io- 3 M)

Specific Ac ti vi ty l, 2
(µmoles 02 /min/mg protein)

Fe( III)

100

Cu(I I)

0

Mg(II)

0

Ni (I I)

0

Al(III)

0

Co(II)

0

Mn( II)

0

Mo( VI)

0

1Reaction mixture consists of 0.6 MAcetate buffer (pH 6.0) diluted
1 to 3, 50 µl (0.409 mg) of purified ferroxidase-II and a final cation
concentration of 1 x l0-3M.
2These values represent the specific activity with ferroxidase-II and
the cation in the absence of Fe(III). Inhibition by Cu(Il) was noted
when Fe(III) was introduced into the reaction vessel containing 1 x l0-3M
Cu(II) and ferroxidase-II.
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reaction vessel to determine the effect, if any, of the various metals
upon the Fe(III)-initiated reaction.

Copper(II) was the only ion found

to have a significant effect (Figure 5).

As indicated, the presence of

Cu(II) in the reaction mixture resulted in a 55% loss in activity with
Fe(III).

Since copper is an integral part of ferroxidase-II, it may seem

odd that inhibition is observed with exogenously added copper.

However,

it must be remembered that this is an unusually high level of free copper
which greatly increases the chances of non-specific binding of copper.
The copper naturally bound to copper-containing enzymes represents
only a very small percentage by weight of the enzyme. This copper is
normally very tightly bound at specific sites in the enzyme structure.
However, many proteins possess the capability of loosely binding copper,
particularly if they possess sulfur or nitrogen containing amino acids (1).
The binding of copper or other heavy metals at these sites frequently
alters the molecular structure of an enzyme and results in its inactivation.
Possible Involvement of Fe(III) with an Endogenous Substrate
The finding that oxygen consumption follo\'1ed injection of Fe(III)
suggested that iron might serve as an intermediary electron carrier for
the coupling of electron transfer from an endogenous substrate to ferroxidase-II.

A possible mechanism for the Fe(III)-coupled reaction is

as follows:

Substrate 0 x ~2 Fe(!!)
Substrate re d

2 Fe(III)

To test whether this mechanism was feasible, it was necessary to show that
during the course of the reaction ferric iron was reduced to the ferrous state
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FIGURE 5
Effect of Copper(II) upon the Fe(III)-initiated reaction with
Ferroxidase-II
Enzymic assays were performed as described in 11 Experimental Methods 11 •
The control assay mixture contained 50 µl (0.909 mg) of purified ferroxidaseII, 0.2 M acetate buffer, pH 6.0, and an Fe(III) concentration of l x 1Q-3M.
In the second assay mixture, Cu(II) (l x 10- 3 Mfinal concentration) was
allowed to incubate with the enzyme prior to the addition of Fe(III).
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Certain chelating agents, notably a,a'-dipyridyl and l ,10-phenanthro- _
line, complex with ferrous iron.
absorption maximum.

These complexes exhibit characteristic

The phenanthroline complex has an absorption maximum

at 510 nm, while the dipyridyl maximum is at 520 nm (39,40).

Thus, it

should be possible to trap the ferrous ion with 1 ,10-phenanthroline or a,a'dipyridyl as it is produced in the proposed reaction scheme.

This would

prevent reoxidation of the ferrous ion by ferroxidase-II and little, if any,
oxygen consumption should be observed.
When ferroxidase-II was incubated with Fe(III) in the presence of l,
10-phenanthroline, a distinct absorption maximum at 510 nm appeared.

The

appearance of this peak was indicative of the formation of the Fe(II)-phenanthroline complex.

The absorption band at 510 nm increased as a function

of the reaction time (Figure 6).

Analogous results were obtained when a,a'-

dipyridyl was substituted for 1, 10-phenanthroline.

In this case, the ab-

sorption band appeared at 520 nm, the characteristic Amax for the a,a'-dipyridj
ferrous complex (Figure 7).

Control spectra were run to ascertain that none

of the reaction components absorbed at either 510 nm or 520 nm (Figure 8)
Furthermore, no oxygen consumption was observed with reaction mixtures of
a composition identical to those used for these spectral studies.
These results strongly support the proposed role of iron as an intermediary electron carrier for the coupling of electron transfer from an endogenous substrate to ferroxidase-II.
Effect of Fe(III) on the Fe(II) rate with Ferroxidase-II and the Effect of
Fe(II) on the Fe(III) rate with Ferroxidase-II
In view of our proposed mechanism, it was felt that it would be interesting to study the effect of pretreatment of ferroxidase-II with Fe(III)
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FIGURE 6
Iton Chelating·studies Involving l

,10-Phenanthrolin~

The iron-chelating agent spectra were recorded using a Perkin-Elmer
Model 450 UV-visible NIR spectrophotometer.

Spectra were recorded at

various times after addition of the enzyme.
Reference cell: reaction mixture(0.2 MAcetate buffer, pH 6.0)
containing 1 x io- 2 M 1,10-Phenanthroline, 1 x lo-3M Fe(III),
100 µl of 0.05 MAcetate buffer, pH 5.5
Sample cell: reaction mixture(0.2 MAcetate buffer, pH 6.0) containing 1 x 10- 2 M1 ,10-Phenanthroline, l x l0-3 M Fe( III), 100
µl(0.91 mg) ferroxidase-II
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FIGURE 7

Iron·chelating Studies Involving a,a'-Dipyridyl
The iron-chelating agent spectra were recorded using a Perkin-Elmer
Model 450 UV-visible NIR spectrophotometer.

Spectra were recorded at

various times after addition of the enzyme.
Reference cell: reaction mixture(0.2 MAcetate buffer, pH 6.0)
containing 1x10- 2 Ma,a'-Dipyridyl, 1x10- 3 M Fe(III), 100 µl
of 0.05 MAcetate buffer, pH 5.5
Sample cell: reaction mixture(0.2 MAcetate buffer, pH 6.0) containing 1 x 10- 2 Ma,a' -Dipyridyl, 1 x 10- 3 M Fe( III), 100 µl
(0.91 mg) ferroxidase-II
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FIGURE 8
Control Spectra for Studies Involving Iron Chelating Agents
These spectra were recorded using a Perkin-Elmer Model 450 UV-visible
NIR spectrophotometer.

Curve A
Reference cell: reaction mixture(0.2 MAcetate buffer, pH 6.0),
100 µl of 0.05 M Acetate buffer, pH 5.5
Sample cell: reaction mixture(0.2 M Acetate buffer, pH 6.0), 100 µl
(0.91 mg) ferroxidase-II
Curve B
Reference cell: reaction mixture(0.2 MAcetate buffer, pH 6.0),
100 µl of 0.05 MAcetate buffer, pH 5.5, 1 x 10-3 M Fe( III)
Sample cell: reaction mixture(0.2 MAcetate buffer, pH 6.0), 100 µl
(0.91 mg) ferroxidase-II, l x lo-3M Fe(III)
Curve C
Reference cell: reaction mixture(0.2 MAcetate buffer, pH 6.0)
containing 1 x 10- 2 Ma,a'-Dipyridyl, 100 µl of 0.05 MAcetate
buffer, pH 5.5
Sample cell: reaction mixture(0.2 MAcetate buffer, pH 6.0) containing 1 x 10- 2 Ma,a'-Dipyridyl, 100 µl(0.91 mg) ferroxidase-II
Curve D
Reference cell: reaction mixture(0.2 MAcetate buffer, pH 6.0)
containing l x 10- 2 Ml ,10-Phenanthroline, 100 µl of 0.05 MAcetate
buffer, pH 5.5
Sample cell: reaction mixture(0.2 MAcetate buffer, pH 6.0) containing 1 x 10- 2 M 1,10-Phenanthroline, 100 µl(0.91 mg) ferroxidase-I:
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upon the rate of Fe(II} oxidation and the effect of pretreatment of ferroxidase-II with Fe(II} upon the Fe(III}-initiated reaction.
Ferroxidase-II was incubated with various levels of Fe(III) (10 µM to
250

~M)

for two minutes prior to the introduction of Fe(II) into the reaction

vessel. The rate of Fe(II) oxidation was decreased at all Fe(III) concen-trations but with Fe(III) concentrations of 50 µM or greater, there was
little, if any, oxygen consumption when Fe(II) was added (Figure 9).
Similar observations were made when the enzyme was preincubated with
Fe(II) (6 µM to 120 µM) (Figure 10}.

With 30 µM Fe(II), the Fe(III) rate

was reduced by 50% and at those Fe(II) concentrations examined above this,
there was no measurable Fe(III) rate.
These findings provide further evidence for the cycling mechanism.
According to this mechanism, Fe(III) is reduced to Fe(II) which is in turn
reoxidized to Fe(III).

If this is true, then the reaction could be initiated

by either Fe(II) or Fe(III} and should continue until the endogenous substrate is used up.

Thus, if the

reac~ion

is allowed to go to completion,

additional Fe(II) or Fe( III) would have no effect.

As indicated, these

findings definitely support the cycling nature of iron.
Treatment of Ferroxidase-II with OTC
Previous studies (41) have demonstrated that the electrons removed
during Fe(II) oxidation by ferroxidase-II are passed to oxygen via the
copper bound to ferroxidase-II.

The mechanism previously illustrated for

the coupling of Fe(III) with an endogenous substrate would require that
electrons from the endogenous substrate also be passed to oxygen via the
copper bound to ferroxidase-II.
OTC specifically binds Cu(II) and prevents its reduction (42).

Almost
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FIGURE 9
Effect of Fe(III) on the Fe( II) rate with Ferroxidase-II
Enzymic assays were performed as described in "Experimental Methods".
In each assay, 50 µl(0.455 mg) of ferroxidase-II and varying concentrations
of Fe(III) were allowed to incubate for two minutes prior to the addition
of 100 µl of 26.4 x l0- 4 M Fe(II)(l20 µM).
age of three separate experiments.

Each point represents the aver-

The average specific activity of Fe(II)

and ferroxidase-II in the absence of Fe(III) was 133 µmoles 02 /min/mg protein.
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FIGURE 10
Effect of Fe( II) on the Fe( III) rate with Ferroxidase-II
Enzymic assays were performed as described in "Experimental Methods".
In each assay, 50 µl (0.455 mg) of ferroxidase-II and varying concentrations
of Fe(II) were allowed to incubate for two minutes prior to the addition
of 0.2 µl of 1 MFe(III) which yields a final Fe(III) concentration of
100 µM.

The increase in the specific activity resulting from the addition

of Fe(III) was recorded.

The average specific activity of Fe(III) and

ferroxidase-II in the absence of Fe(II) was 150 µmoles 02 /min/mg protein.
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total loss of Fe(III)-initiated activity was observed with the OTC treated
enzyme (Table 3). These results suggest that if electrons originate from
an endogenous substrate via an Fe(III)-coupled reaction they also ultimately
pass through the ferroxidase-II bound copper in route to oxygen.
Search for Identity of Endogenous Substrate
After determining the kinetic parameters of the Fe(III)-initiated
reaction with ferroxidase-II and obtaining evidence that indicated that
Fe(III) could serve as an intermediary electron carrier from the endogenous
substrate to the copper of ferroxidase-II, the next step was to attempt to
identify the endogenous substrate responsible for this activity.
Catecholamines as Potential Substrates
Ferroxidase-lI was purified from blood serum so, it seemed logical
to examine some components of blood as potential endogenous substrates.
Walaas et al (43) found that ferroxidase-1 had some oxidase activity
with the catecholamines:

epinephrine, norepinephrine and dopamine .. To

further differentiate betv1een ferroxi dase- I and II, and in the hope of
identifying the endogenous substrate with ferroxidase-11, the catecholamines
were examined to see if they could serve as a substrate for ferroxidase-II.
In addition to the catecholamines mentioned, serotonin and ascorbic acid
were also studied as potential substrates.

Each compound was made up in

the reaction mixture to which the ferroxidase-11 and the Fe(lII) were injected.
None of the substances tested were found to stimulate the ferroxidase
activity.

Thus, it appeared that none of the catecholamines were capable

of serving as a substrate for ferroxidase-II.
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TABLE 3
Effect of OTC on Oxygen Consumption Initiated by Fe(III)a

Specific Activity
{µM 02 /min/rng protein)
Fe( II)
(1.2 x 10- 4 M)
Control

Fe( II I)
( 1 x 10- 2 M)

102.8

83.9

OTC-Treated

28.4

7.3

% Inhibition

72.4

91. 3

aDTC treatments and enzyme assays were performed as described in
"Experimental Methods
11
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Treatment of Ferroxidase-11 with Phospholipase C
Recent work by C.S.M. Sung (32) showed that ferroxidase-II was a
lipoprotein having cholesterol as well as phospholipids tightly associated
with it.

She observed a very large decrease in the ferroxidase activity

of samples which had been treated with Phospholipase C.

Phospholipases

are enzymes which catalyze the hydrolysis of phospholipids at the specific
points illustrated below (44):
Phospholipase B

/

Phospholipase A

·

~

H 2 CO~C-R1
--111
0

R2-c~LocH
uT
0

_LH+

?'l- ~CH3)2
0

Phospholipase C

+

Phospholipase D

Phospholipase C hydrolyzes the bond between phosphoric acid and glycerol
to form a l ,2-diglyceride and a water-soluble phosphorylcholine.
Sung's (32) observation that ferroxidase activity was lost after
phospholipase treatment indicated that the lipids were essential for the
maintenance of enzymic activity.

This led to the idea that the endogenous

substrate for the Fe(III)-initiated ferroxidase reaction might be a lipid
or at least bound in the lipid matrix of the enzyme.
To test this hypothesis, three different ferroxidase-II preparations
were treated with Phospholipase C and examined for loss of Fe(III)-initiated
activity.

As seen in Table 4, hydrolysis with Phospholipase C resulted

in a dramatic loss of activity with both Fe(II) and Fe(III).

To completely

remove the hydrolyzed lipids, portions of the Phospholipase C treated
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TABLE 4
Effect of Phospholipase C treatment on Ferroxidase-II Activity

Treatment

Specific Activity
...U1mo l es O~_mi nlm l .nr_ot__ein_l
l x l0-3 M Fe(III) l. 2 x 10- 4 M Fe(I I)

None

88.5

139.2

Phospholipase C treatedl

22.3

21.2

0

0

Phospholipase C treated,
passed over Agarose A-5m 1

lSimilar losses in activity were observed after each step with all
three enzyme preparations.
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enzyme were passed over an Agarose A-Sm column (2.5 cm x 27 cm).

This

procedure resulted in a total loss of activity with Fe(II) as well as
Fe(III).

These findings suggest that the endogenous substrate may be a

lipid or bound in the lipid matrix of the enzyme.
Examination of Lipid Components of Ferroxidase-II
The finding that the phospholipase C treatment of ferroxidase-II
resulted in the loss of activity with the Fe(III)-initiated reaction suggested that the endogenous substrate might be lipid in nature.

To further

investigate this, a purified lipid extract was prepared from ferroxidase-II
(see experimental), dissolved in various solvents then introduced into
the reaction vessel with Fe(III) and ferroxidase-II.

This was designed to

determine the extent, if any, of stimulation of the Fe(III)-initiated reaction by the addition of these lipids which had been extracted from ferroxi dase-I I.
Purified Lipids in Normal Reaction Mixture
The lipid extract was insoluble in the normal reaction mixture(0.6 M
acetate buffer, pH 6.0) so the solution was homogenized to form a uniform
suspension.

The results of this experiment (TableJ5) indicate that the

addition of the lipids as a buffer suspension caused no increase in activity.
Although there appeared to be no stimulation, it is possible that
the lipids were unable to participate in the reaction because they were
insoluble in the reaction system.

Thus, different solvent systems were

examined.
Purified Lipids in Triton X-100
The 1i pi d extract was ·readily so 1ub1 e in a 10% so 1uti on of Triton

TABLE 5

Examination of Lipid Components of Ferroxidase-II
as Possible Substratesl,2
Specific Activity
(µMoles 02 /min/mg protein)
Trial 1 Trial 2 Trial 3 Average
Fe(III), Ferroxidase-II

70.4

67.5

0.145 mg lipid extract, Fe(III), Ferroxidase-II

71.8

67.5

1.45 mg lipid extract, Fe(III), Ferroxidase-II

67.5

67.5

Fe(III), delipidized Ferroxidase-II3

0

0

Fe(III), delipidized Ferroxidase-II3,
0.145 mg lipid extract

0

0

68.9

71.8

69.9

01

lNormal reaction mixture (0.2 MAcetate buffer, pH 6.0) used as solvent
2Lipid insoluble, homogenized to form uniform suspension
3has been through Agarose A-5m

w
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X-100 but there was too much oxygen consumption due to the auto-oxidation
of the Triton solution.

Because of this problem, the Triton system could

not be used in these studies.
Purified Lipids in 50% Glycerol
The lipid extract was suspended in a 50% glycerol solution but there
was no increase in activity noted.
Purified Lipids in n-Hexane
The lipid extract was also found to be soluble in hexane.

Additions

of lipids in a hexane solution caused a slight increase in oxygen consumption but, this was attributed to the hexane rather than the lipids.
Purified Lipids in Diethyl Ether and Tetrahydrofuran
Both diethyl ether and tetrahydrofuran were found to be excellent
solvents for the lipid extract; however, when these solvents were injected
into the reaction vessel with ferroxidase-II and Fe(III), total inhibition
of ferroxidase activity was observed.

Since tetrahydrofuran and diethyl

ether inactivated the enzyme, they could not be used in these studies.
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DISCUSSION
Ferric iron v!as first examined to determine its inhibitory effect
upon ferroxidase-II; however, quite surprisingly, an Fe(III)-initiated
oxidase reaction with ferroxidase-II was observed.

Because of this un-

expected finding, a thorough investigation of this Fe(III)-initiated
reaction was undertaken.
The finding that saturation kinetics were observed with the Fe(III)initiated reaction and that heat treatment resulted in the loss of this
activity suggested that the oxidase reaction was an enzymic process.
To explain the Fe(III)-initiated reaction, a mechanism involving iron
as an intermediary electron carrier for the coupling of electron transfer

x

x

from an endogenous substrate to ferroxidase-II was proposed:
· substrate 0 xxFe(II)

Substrate red

Fe ( III )

Foxox(curl)
Foxred(CuI)

H2o
i

/202

Several pieces of experimental evidence led to the formulation of this
mechanism and support it as a feasible explanation of the Fe(III)-initiated
oxidation reaction.
(1) Spectral studies with Fe(II) chelating agents demonstrate
that ferric iron is reduced to the ferrous state in the
presence of ferroxidase-II.
(2) The trapping of the ferrous ion by these chelating agents

would prevent its reoxidation and halt oxygen consumption.
No oxygen consumption \·1as observed when these ch elating
agents were included in the reaction mixture at concentrations sufficient to completely trap all of the ferrous
iron produced.

(3) This mechanism suggests that Fe(II) and Fe(III) are parti-

cipating at the same site on the enzyme. The kinetic parameters
of ferroxidase-II with Fe(III) and Fe(II) were found to be
quite similar. The Km for each was quite low and their maximal
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(3) velocities were nearly equal. The pH optima found with
Fe(III) and Fe(II) were comparable and the fact that they
are in the vicinity of neutrality indicates that they
would be compatible with the pH of blood.
(4) The mechanism would suggest that the reaction of the endogenous substrate with ferroxidase-II could be initiated
by either Fe(II) or Fe(III) and this reaction would continue until oxidation of the endogen9us substrate was
complete. A two minute preincubation of the enzyme with
either Fe(II) or Fe(III) was found to considerably reduce
further oxygen cons ump ti on \I/hen addi ti ona 1 Fe(I I I) or
Fe(II) was added.
(5) The mechanism would also imply that the copper associated
with ferroxidase-II is actively involved in the shuttle
of electrons from the endogenous substrate to oxygen. The
potent inhibition of the Fe(III)-initiated oxygen consumption observed with diethyl-dithio-carbamate(DTC), a
copper specific chelating agent, strongly suggests that
the copper associated with ferroxidase-II must be involved
in this reaction.
(6) The enzymic reaction was initiated specifically by iron
and substitution by other transition elements resulted
in no oxygen consur1:ption. Thus, iron must be ideally
suited to participate in the coupled reaction with the
endogenous substrate. This indicates that the site on
the enzyme at which this reaction takes place must have
some features which make it compatible only with iron.
Indeed the reduction potent}al of protein-bound iron
has been found to be more negative than that of proteinbound copper(45). Thus, it would seem logical for iron
to be~the initial acceptor of electrons and to pass
these electrons to copper which in turn would transfer
the electrons to oxygen.
Considerable evidence suggested that the proposed mechanism was feasible.

Thus, investigations concerning the isolation and identification of

the endogenous substrate(or source of endogenous reducing power) were initiated. This presented quite a problem since the substrate appeared to
be very tightly bound to the enzyme.

The substrate remained associated

with the enzyme through an organic solvent precipitation, an ion exchange
chromatographic step, ultrafiltration and two gel filtration columns.
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These purification steps should have removed any impurities or loosely
bound substances.
Initially, various oxidizable components of human blood were examined
in the hopes of finding one which would stimulate the Fe(III)-initiated
reaction.

None of the substances studied caused significant increases in

activity, so it was decided to approach the problem by an alternative
method.
The loss in activity following the hydrolysis of the phospholipids
associated with ferroxidase-II suggested that the endogenous substrate
was a lipid or was bound in the lipid matrix of the enzyme.

This prompted

studies with lipid extracts from ferroxidase-II, but numerous problems
were encountered.
Attempts to restore the activity of delipidized ferroxidase-II were
unsuccessful; however, this failure can be explained in several ways.
Perhaps the most obvious answer is that the phospholipase C treatment
caused an irreversible alteration in the enzyme's three dimensional structure thus rendering it inactive.
be observed.

If this were the case, no activity should

Difficulties were also encountered in finding a corrmon sol-

vent for the lipid extract and the enzyme.

Since the lipids are insoluble

in an aqueous mixture, it was necessary to find a solvent which would expose them to the enzyme.

Unfortunately, all of the solvents in which the

enzyme and lipids were mutually soluble were found to inactivate the native
enzyme.

Because of this, our studies were done using suspensions of the

lipids rather than solutions.

This does not assure good interaction be-

tween the enzyme and lipids, so the fact that no activity was observed does
not conclusively prove that the substrate was not present in the lipid
extract.

58

Assuming that the phospholipase C treatment might be irreversibly
altering the enzyme's three dimensional structure, a third approach for
i denti fyi ng the endogenous substrate \\las attempted.

Rather than adding

the lipid extract to the delipidized ferroxidase-II, it was added to native ferroxidase-II.

This approach suffered from problems similar to

those encountered with the delipidized enzyme.

Here again, a suitable

solvent for the enzyme and substrate was not found.

This lack of a com-

mon solvent turned out to be the major stumbling block in the studies
with the lipid extracts.
This is an interesting area which might be explored further, but to
pursue the theory that the endogenous substrate is a lipid, it would be
necessary to effect a separation of the individual lipids present in the
lipid extract.

Then, it would be possible to make more concentrated sol-

utions of the individual lipids and examine them to see if they increase
the activity of the Fe(III)-initiated reaction.
Even if the lipid responsible for this activity were isolated, it is
possible that no increase in activity would be observed.

It should be

remembered that in the native enzyme the substrate is already attached to
the enzyme.

It is likely that the enzyme and exogenous lipid would not

come together in such a manner as to duplicate the binding of the enzyme
and substrate in the native complex.
Recently, a quinone-like substance, capable of being oxidized and reduced, has been isolated from ferroxidase-II.

Although the substance has

not yet been definitely identified, it appears to be part of the lipid
matrix and is extremely similar to quinones found in living systems.

Based

upon its chromatographic (column and TLC) behavior, spectral data, and
chemical tests, the substance is very much like ubiquinone (46).

As of
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this date, sufficient quantities have not been obtained for definitive
identification or for substrate studies.
Once sufficient quantities have been isolated, it would be interesting
to compare its structure before and after treatment with iron.

It should

be possible to determine whether there is an alteration in its structure ·
and whether or not it is being oxidized.
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